• 제목/요약/키워드: Cancer treatments

검색결과 783건 처리시간 0.027초

치료 방법에 따른 유방암 환자의 피로와 삶의 질 (Comparison of Fatigue and Quality of Life in the Women with Breast Cancer According to two Different Treatment Modalities : Chemotherapy vs Radiotherapy)

  • 양영희
    • 한국간호교육학회지
    • /
    • 제9권2호
    • /
    • pp.244-252
    • /
    • 2003
  • This study was intented to identify the differences of fatigue and quality of life in patients with breast cancer according to the different treatment modalities. Ninety-one subjects were recruited from a medical unit and a therapeutic radiologic clinic at a university hospital in Chungnam, Korea. Fatigue was measured using Lee's scale(1999) translated from Piper's Fatigue Scale and quality of life was measured using Yang's scale(2002). The women with breast cancer receiving chemotherapy were less fatigued and had better quality of life than those receiving radiotherapy(t=-2.914, p=.005; t=2.565, p=.012, respectively). The fatigue and quality of life in the women with breast cancer undergoing cancer treatments were influenced by the weight change during the past 3 months(F=24.70, p=.039). Cancer stage, metastasis and weight were not associated with fatigue and quality of life. Health professionals can help cancer patients undergoing treatments prepare to cope with the expected side effects by providing a specific treatment-related information to them. The findings of this study can contribute the knowledge of these information.

  • PDF

항문암 수술 후 혈중 항뮬러관 호르몬 저하 및 자궁내막이 얇은 난임 환자의 한약치료 자연임신 1례 (Korean Medical Treatment’s Report about a Spontaneous Pregnancy with Low Anti-Müllerian Hormone (AMH) Level and Thin Endometrium Infertility after Anorectal Cancer Surgery)

  • 고지은;유명숙
    • 대한한방부인과학회지
    • /
    • 제29권3호
    • /
    • pp.68-77
    • /
    • 2016
  • Objectives: This paper is to report a spontaneous pregnancy with low AMH level and thin endometrium infertility after Korean medical treatments.Methods: A 38-year old patient who had low AMH level, thin endometrium, sleep disturbance and anxiety happened after anorectal cancer surgery was treated by korean medicine such as herb medications per day for 6 months. And we observed the effects of treatments by improvement of symptoms checking endometrium ultrasonography.Results: After treatments, Symptoms of anxiety and sleep disturbance were improved. The number of ovarian follicle and endometrium thickness were upgraded during artificial pregnancy trials. Finally the patient was a spontaneous pregnancy after failures of one intrauterine insemination and one in vitro fertilization trial.Conclusions: This case shows that the korean medicine has effective option for a patient with low AMH level and thin endometrium infertility. Further ultrasonography would be valid measurements to check the effectiveness of oriental treatments as well as symptoms.

난소암의 항암화학요법 유발 만성 말초신경병증의 조리폐원탕 및 복합한의치료 치험 1례 (Korean Medicine Treatments with Joripewon-tang for Chemotherapy-Induced Peripheral Neuropathy of Ovarian Cancer : Case Report)

  • 염지윤;김수현;오승윤;박수정
    • 대한암한의학회지
    • /
    • 제27권1호
    • /
    • pp.49-56
    • /
    • 2022
  • Objective: This case report represented that Korean traditional medicine therapies can make effective results for chemotherapy-induced peripheral neuropathy(CIPN) patients. Methods: A 63-year-old female patient has been diagnosed with ovarian cancer(Sertoli-Leydig cell tumor). Total excision of uterus and appendages was operated, and Bleomycin, etoposide and cisplatin combination therapy was applied. After three cycles of chemotherapy, the severe side effects of neutropenia and CIPN occurred. Chemotherapy was terminated, but numbness and tingling pains in the limbs persisted for several months. We provided Korean medicine treatments including herbal medicine, pharmacopuncture, acupuncture, moxibustion and physiotherapies. Results: After treatments, the numbness and pain were reduced from 10 to 1 in hand and 6 to 0 on the numeric rating scale(NRS). Functional assessment of cancer therapy/Gynecologic oncology group neurotoxicity (FACT/GOG-NTX) score was improved from 58 to 97. Conclusion: According to these results, Korean medicine treatments could be considered effective for CIPN. Prospective studies are needed to confirm and expand these findings.

Metabolic Profiling of Urine Samples from Colorectal Cancer Patients Before and After Surgical Treatments

  • Chae, Young-Kee;Kang, Woo-Young;Kim, Seong-Hwan;Joo, Jong-Eun;Han, Joon-Kil;Hong, Boo-Whan
    • 한국자기공명학회논문지
    • /
    • 제14권1호
    • /
    • pp.28-37
    • /
    • 2010
  • Metabolites of urine samples from 6 colorectal cancer patients were analyzed by two-dimensional NMR spectroscopy, where the samples were collected before and after the surgical treatments per patient. NMR data were analyzed with the help of the metabolome database and the statistics software. Urine samples before and after the treatments showed significantly different metabolic profiles from each other. We were able to compare 10 different metabolites. Most of the assigned metabolites of every patient showed a tendency of increase after the surgery except for a few cases. The amount of changes in individual metabolites varied significantly from patient to patient, but the combination of such changes could be used to distinguish the condition before the surgery from after, which could be done by PCA analysis. The analysis via $^{1}H-^{13}C$ HSQC spectra proved to be applicable in assessing and classifying global metabolic profiles of the urines from colorectal cancer patients.

한방 치료에 대한 암 환자의 인식 조사 : 단면조사연구 (Perspectives of Cancer Patients on Korean Medicine Treatments: A Cross-sectional Survey)

  • 류한성;윤성수;이지영;윤성우
    • 대한한방내과학회지
    • /
    • 제38권3호
    • /
    • pp.319-326
    • /
    • 2017
  • Objective: The purpose of this study was to survey the general perspectives of cancer patients on Korean medicine (KM) treatments. Method: The after focus-group discussion consisted of six cancer patients. The questionnaire items were decided. Fifty randomized cancer patients completed the online survey questionnaire regarding the perspectives of KM in cancer treatment. Results: Cancer patients considered KM to be a treatment performed both by KM doctors (92%) and by others (46%), such as private practitioners. Cancer patients thought of KM treatment as effective (68%) and safe (64%), but not scientific (60%). The answers of the cancer patients regarded whether the KM treatment experiences were different in purpose, satisfaction, and types of KM treatment. The experienced KM cancer patients thought of the optimal purpose of KM as alleviating symptoms or side effects (73.7%). Experienced patients were more satisfied with KM and they preferred acupuncture and moxibustion to thermotherapy. Conclusion: Cancer patients consider KM treatment effective and safe, but not scientific. Cancer patients who are experienced with KM are favorable to KM treatment. The direction of future studies of KM in cancer care should be considered based on these findings.

Enhanced Anti-cancer Efficacy in MCF-7 Breast Cancer Cells by Combined Drugs of Metformin and Sodium Salicylate

  • Kim, Yun-Ji;Park, Hee-Bin;Kim, Pyung-Hwan;Park, James S.;Kim, Keun-Sik
    • 대한의생명과학회지
    • /
    • 제23권3호
    • /
    • pp.290-294
    • /
    • 2017
  • Metformin or sodium salicylate is known to induce apoptosis and G0/G1 phase arrest in a variety of cancer cells. However, the anti-cancer effects of the combined treatments for these drugs-induced apoptosis are yet unclear. Here, we found that the combined treatment of metformin and sodium salicylate increased the efficacy of chemotherapeutics against breast cancer cells. These combined drugs significantly inhibited cellular proliferation and induced apoptosis at an earlier stage in human MCF-7 breast cancer cells. Also, co-treatments of metformin and sodium salicylate induced G1 cell cycle arrest in MCF-7 cells more effectively than either agent alone. Taken together, these results demonstrate that dual metformin/sodium salicylate treatment prevents proliferation of MCF-7 cells by inducing apoptosis and G1 cell cycle arrest.

Emerging Targets for Systemic Treatment of Gastric Cancer: HER2 and Beyond

  • In-Ho Kim
    • Journal of Gastric Cancer
    • /
    • 제24권1호
    • /
    • pp.29-56
    • /
    • 2024
  • In recent years, remarkable progress has been made in the molecular profiling of gastric cancer. This progress has led to the development of various molecular classifications to uncover subtype-specific dependencies that can be targeted for therapeutic interventions. Human epidermal growth factor receptor 2 (HER2) is a crucial biomarker for advanced gastric cancer. The recent promising results of novel approaches, including combination therapies or newer potent agents such as antibody-drug conjugates, have once again brought attention to anti-HER2 targeted treatments. In HER2-negative diseases, the combination of cytotoxic chemotherapy and programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) inhibitors has become the established standard of care in first-line settings. In the context of gastric cancer, potential biomarkers such as PD-L1 expression, Epstein-Barr virus, microsatellite instability, and tumor mutational burden are being considered for immunotherapy. Recently, promising results have been reported in studies on anti-Claudin18.2 and fibroblast growth factor receptor 2 treatments. Currently, many ongoing trials are aimed at identifying potential targets using novel approaches. Further investigations will be conducted to enhance the progress of these therapies, addressing challenges such as primary and acquired resistance, tumor heterogeneity, and clonal evolution. We believe that these efforts will improve patient prognoses. Herein, we discuss the current evidence of potential targets for systemic treatment, clinical considerations, and future perspectives.

Current Status of Immunotherapy for Lung Cancer and Future Perspectives

  • Kim, Ho Cheol;Choi, Chang-Min
    • Tuberculosis and Respiratory Diseases
    • /
    • 제83권1호
    • /
    • pp.14-19
    • /
    • 2020
  • Lung cancer remains the most common cause of cancer-related deaths worldwide. Although there are many possible treatments, including targeted therapies such as epidermal growth factor receptor tyrosine kinase inhibitors and anaplastic lymphoma kinase inhibitors, new therapeutic strategies are needed to improve clinical outcomes. Immunotherapy through the use of immune checkpoint inhibitors has provided one of the most important breakthroughs in the management of solid tumors, including lung cancers, and has shown promising results in numerous clinical trials. This review will present the current status of immunotherapy for lung cancer and future perspectives on these treatments.

방광암 후유증 환자 치험 1례 (Clinical Study for the One Case that Sequela of Bladder Cancer Patient Treatments by Korean Medicine)

  • 조성희;송유림
    • 대한한방부인과학회지
    • /
    • 제28권2호
    • /
    • pp.156-164
    • /
    • 2015
  • Objectives : This study aims to report the effect of Korean medicine treatment on Sequela of Bladder Cancer. Methods : The patient was treated with korean medicine of Paljeongsan-gamibang, acupuncture at Qihai (CV6), Guanyuan (CV4), Qugu (CV2), Hyeolhae (SP10), Sameumgyo (SP6) and we evaluated treatment effects by visual analogue scale (VAS) and urine analysis (UA) finding. Results : After treatments, the symptoms such as perineal pain, painful urination, dysuria, anorexia were improved and taking number of narcotic analgesic was reduced. Conclusions : This clinical study suggests that korean medicine treatment shows possibility to care for sequela of bladder cancer patient.

Neuropathic cancer pain: prevalence, pathophysiology, and management

  • Yoon, So Young;Oh, Jeeyoung
    • The Korean journal of internal medicine
    • /
    • 제33권6호
    • /
    • pp.1058-1069
    • /
    • 2018
  • Neuropathic cancer pain (NCP) is caused by nerve damage attributable to the cancer per se, and/or treatments including chemotherapy, radiotherapy, and surgery; the prevalence is reported to be as high as 40%. The etiologies of NCP include direct nerve invasion or nerve compression by the cancer, neural toxicity, chemotherapy, and radiotherapy. NCP is subdivided into plexopathy, radiculopathy, and peripheral neuropathies, among several other categories. The clinical characteristics of NCP differ from those of nociceptive pain in terms of both the hypersensitivity symptoms (burning, tingling, and an electrical sensation) and the hyposensitivity symptoms (numbness and muscle weakness). Recovery requires several months to years, even after recovery from injury. Management is complex; NCP does not usually respond to opioids, although treatments may feature both opioids and adjuvant drugs including antidepressants, anticonvulsants, and anti-arrhythmic agents, all of which improve the quality-of-life. This review addresses the pathophysiology, clinical characteristics and management of NCP, and factors rendering pain control difficult.